Moya-Garzon, M.D.; Gomez-Vidal, J.A.; Alejo-Armijo, A.; Altarejos, J.; Rodriguez-Madoz, J.R.; Fernandes, M.X.; Salido, E.; Salido, S.; Diaz-Gavilan, M.
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. J. Pers. Med. 2021, 11, 74.
https://doi.org/10.3390/jpm11020074
AMA Style
Moya-Garzon MD, Gomez-Vidal JA, Alejo-Armijo A, Altarejos J, Rodriguez-Madoz JR, Fernandes MX, Salido E, Salido S, Diaz-Gavilan M.
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of Personalized Medicine. 2021; 11(2):74.
https://doi.org/10.3390/jpm11020074
Chicago/Turabian Style
Moya-Garzon, Maria Dolores, Jose Antonio Gomez-Vidal, Alfonso Alejo-Armijo, Joaquin Altarejos, Juan Roberto Rodriguez-Madoz, Miguel Xavier Fernandes, Eduardo Salido, Sofia Salido, and Monica Diaz-Gavilan.
2021. "Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias" Journal of Personalized Medicine 11, no. 2: 74.
https://doi.org/10.3390/jpm11020074
APA Style
Moya-Garzon, M. D., Gomez-Vidal, J. A., Alejo-Armijo, A., Altarejos, J., Rodriguez-Madoz, J. R., Fernandes, M. X., Salido, E., Salido, S., & Diaz-Gavilan, M.
(2021). Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of Personalized Medicine, 11(2), 74.
https://doi.org/10.3390/jpm11020074